{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "complications",
      "miRNA",
      "prognosis",
      "therapeutic",
      "virus"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35062245",
  "DateCompleted": {
    "Year": "2022",
    "Month": "02",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "41",
      "10.3390/v14010041"
    ],
    "Journal": {
      "ISSN": "1999-4915",
      "JournalIssue": {
        "Volume": "14",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec",
          "Day": "27"
        }
      },
      "Title": "Viruses",
      "ISOAbbreviation": "Viruses"
    },
    "ArticleTitle": "miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.",
    "Abstract": {
      "AbstractText": [
        "The COVID-19 pandemic has been a public health issue around the world in the last few years. Currently, there is no specific antiviral treatment to fight the disease. Thus, it is essential to highlight possible prognostic predictors that could identify patients with a high risk of developing complications. Within this framework, miRNA biomolecules play a vital role in the genetic regulation of various genes, principally, those related to the pathophysiology of the disease. Here, we review the interaction of host and viral microRNAs with molecular and cellular elements that could potentiate the main pulmonary, cardiac, renal, circulatory, and neuronal complications in COVID-19 patients. miR-26a, miR-29b, miR-21, miR-372, and miR-2392, among others, have been associated with exacerbation of the inflammatory process, increasing the risk of a cytokine storm. In addition, increased expression of miR-15b, -199a, and -491 are related to the prognosis of the disease, and miR-192 and miR-323a were identified as clinical predictors of mortality in patients admitted to the intensive care unit. Finally, we address miR-29, miR-122, miR-155, and miR-200, among others, as possible therapeutic targets. However, more studies are required to confirm these findings."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          },
          {
            "Identifier": [],
            "Affiliation": "Escuela Superior de Medicina, Departamento de Posgrado, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico."
          }
        ],
        "LastName": "Bautista-Becerril",
        "ForeName": "Brandon",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Escuela Superior de Medicina, Departamento de Posgrado, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico."
          }
        ],
        "LastName": "P\u00e9rez-Dimas",
        "ForeName": "Guillermo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Ciencias de la Salud, Universidad An\u00e1huac M\u00e9xico Norte, Mexico City 52786, Mexico."
          }
        ],
        "LastName": "Sommerhalder-Nava",
        "ForeName": "Paola C",
        "Initials": "PC"
      },
      {
        "Identifier": [
          "0000-0002-6235-124X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Ciencias de la Salud, Universidad An\u00e1huac M\u00e9xico Norte, Mexico City 52786, Mexico."
          }
        ],
        "LastName": "Hanono",
        "ForeName": "Alejandro",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Organismo P\u00fablico Descentralizado, Servicios de Salud Jalisco, Zapopan City 45010, Mexico."
          }
        ],
        "LastName": "Mart\u00ednez-Cisneros",
        "ForeName": "Julio A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultad de Ciencias de la Salud, Universidad An\u00e1huac M\u00e9xico Norte, Mexico City 52786, Mexico."
          }
        ],
        "LastName": "Zarate-Maldonado",
        "ForeName": "B\u00e1rbara",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Escuela Superior de Medicina, Departamento de Posgrado, Instituto Polit\u00e9cnico Nacional, Mexico City 11340, Mexico."
          }
        ],
        "LastName": "Mu\u00f1oz-Soria",
        "ForeName": "Evangelina",
        "Initials": "E"
      },
      {
        "Identifier": [
          "0000-0002-2869-5516"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio de Biolog\u00eda Molecular, Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          }
        ],
        "LastName": "Aquino-G\u00e1lvez",
        "ForeName": "Arnoldo",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0001-8689-9755"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Epidemiolog\u00eda Hospitalaria e Infectolog\u00eda, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          }
        ],
        "LastName": "Castillejos-L\u00f3pez",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          }
        ],
        "LastName": "Ju\u00e1rez-Cisneros",
        "ForeName": "Armida",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio de C\u00e1ncer Pulmonar, Departamento de Enfermedades Cr\u00f3nico-Degenerativas, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          }
        ],
        "LastName": "Lopez-Gonzalez",
        "ForeName": "Jose S",
        "Initials": "JS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico."
          }
        ],
        "LastName": "Camarena",
        "ForeName": "Angel",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Viruses",
    "NlmUniqueID": "101509722",
    "ISSNLinking": "1999-4915"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MicroRNAs"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "genetics"
      ],
      "DescriptorName": "MicroRNAs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}